Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The implication of monitoring tumour markers: a personalised medicine approach

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: GRECH, Louise (University of Malta, Pharmacy, Attard, Malta)
  • Co-author(s): Charyl Fava: Pharmacy, University of Malta, Msida, Malta
    Louise Grech: Pharmacy, University of Malta, Msida, Malta;Pharmacy, Mater Dei Hospital, Msida, Malta
    Rachel Micallef: Oncology, Sir Anthony Mamo Oncology Centre, Msida, Malta
    Stefan Laspina: Haematology and Oncology, Mater Dei Hospital, Msida, Malta
    Christopher Barbara: Pathology, Mater Dei Hospital, Msida, Malta
    Lilian M. Azzopardi: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    The availability of tumour markers in managing oncology patients contributes to developing personalised pharmacotherapy. 

    Purpose

    To develop and implement a pharmaceutical personalised approach based on harmaceutical care plan (PCP) incorporating tumour markers for patients suffering from ovarian, pancreatic or prostate cancer.

    Methods

    Drug

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses